4.6 Review

Progesterone: the ultimate endometrial tumor suppressor

Journal

TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 22, Issue 4, Pages 145-152

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2011.01.005

Keywords

-

Funding

  1. National Institutes of Health (NIH) [CA99908]
  2. Department of Obstetrics and Gynecology
  3. NIH [CA27469]
  4. Cory Beach Family in honor of Mrs. Barbara Beach

Ask authors/readers for more resources

The uterine endometrium is exquisitely sensitive to steroid hormones that act through well-described nuclear receptors. Estrogen drives epithelial proliferation, and progesterone inhibits growth and causes cell differentiation. The importance of progesterone as a key inhibitor of carcinogenesis is reflected by the observation that women who ovulate and produce progesterone almost never get endometrial cancer. In this review we describe seminal research findings that define progesterone as the major endometrial tumor suppressor. We discuss the genes and diverse signaling pathways that are controlled by progesterone through progesterone receptors (PRs) and also the multiple factors that regulate progesterone/PR activity. By defining these progesterone-regulated factors and pathways we identify the principal therapeutic opportunities to control the growth of endometrial cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available